• レポートコード:QY2203B02393 • 出版社/出版日:QYResearch / 2022年3月 • レポート形態:英文、PDF、94ページ • 納品方法:Eメール(納期:3日) • 産業分類:医薬品 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のカルボプラチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカルボプラチンの世界市場のxxx%を占める「カルボプラチン結晶」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「カルボプラチン注射」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国のカルボプラチンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのカルボプラチン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのカルボプラチン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 カルボプラチンのグローバル主要メーカーには、Teva、Fresenius Kabi、Mylan、Qilu、Taj Pharmaceuticals、Tecoland Corporation、Johnson Matthey、Heraeus Deutschlandなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 カルボプラチン市場は、種類と用途によって区分されます。世界のカルボプラチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 カルボプラチン結晶、カルボプラチン粉末 【用途別セグメント】 カルボプラチン注射、その他 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - カルボプラチン製品概要 - 種類別市場(カルボプラチン結晶、カルボプラチン粉末) - 用途別市場(カルボプラチン注射、その他) - 調査の目的 ・エグゼクティブサマリー - 世界のカルボプラチン販売量予測2017-2028 - 世界のカルボプラチン売上予測2017-2028 - カルボプラチンの地域別販売量 - カルボプラチンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別カルボプラチン販売量 - 主要メーカー別カルボプラチン売上 - 主要メーカー別カルボプラチン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(カルボプラチン結晶、カルボプラチン粉末) - カルボプラチンの種類別販売量 - カルボプラチンの種類別売上 - カルボプラチンの種類別価格 ・用途別市場規模(カルボプラチン注射、その他) - カルボプラチンの用途別販売量 - カルボプラチンの用途別売上 - カルボプラチンの用途別価格 ・北米市場 - 北米のカルボプラチン市場規模(種類別、用途別) - 主要国別のカルボプラチン市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパのカルボプラチン市場規模(種類別、用途別) - 主要国別のカルボプラチン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋のカルボプラチン市場規模(種類別、用途別) - 主要国別のカルボプラチン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米のカルボプラチン市場規模(種類別、用途別) - 主要国別のカルボプラチン市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカのカルボプラチン市場規模(種類別、用途別) - 主要国別のカルボプラチン市場規模(トルコ、サウジアラビア) ・企業情報 Teva、Fresenius Kabi、Mylan、Qilu、Taj Pharmaceuticals、Tecoland Corporation、Johnson Matthey、Heraeus Deutschland ・産業チェーン及び販売チャネル分析 - カルボプラチンの産業チェーン分析 - カルボプラチンの原材料 - カルボプラチンの生産プロセス - カルボプラチンの販売及びマーケティング - カルボプラチンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - カルボプラチンの産業動向 - カルボプラチンのマーケットドライバー - カルボプラチンの課題 - カルボプラチンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Carboplatin Market
Due to the COVID-19 pandemic, the global Carboplatin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Carboplatin Crystal accounting for % of the Carboplatin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Carboplatin Injection segment is altered to an % CAGR throughout this forecast period.
China Carboplatin market size is valued at US$ million in 2021, while the US and Europe Carboplatin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Carboplatin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Carboplatin include Teva, Fresenius Kabi, Mylan, Qilu, Taj Pharmaceuticals, Tecoland Corporation, Johnson Matthey and Heraeus Deutschland, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Carboplatin Scope and Segment
Carboplatin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Carboplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Carboplatin Crystal
Carboplatin Powder
Segment by Application
Carboplatin Injection
Others
By Company
Teva
Fresenius Kabi
Mylan
Qilu
Taj Pharmaceuticals
Tecoland Corporation
Johnson Matthey
Heraeus Deutschland
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Carboplatin Product Introduction
1.2 Market by Type
1.2.1 Global Carboplatin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Carboplatin Crystal
1.2.3 Carboplatin Powder
1.3 Market by Application
1.3.1 Global Carboplatin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Carboplatin Injection
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Carboplatin Sales Estimates and Forecasts 2017-2028
2.2 Global Carboplatin Revenue Estimates and Forecasts 2017-2028
2.3 Global Carboplatin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Carboplatin Sales by Region
2.4.1 Global Carboplatin Sales by Region (2017-2022)
2.4.2 Global Sales Carboplatin by Region (2023-2028)
2.5 Global Carboplatin Revenue by Region
2.5.1 Global Carboplatin Revenue by Region (2017-2022)
2.5.2 Global Carboplatin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Carboplatin Sales by Manufacturers
3.1.1 Global Top Carboplatin Manufacturers by Sales (2017-2022)
3.1.2 Global Carboplatin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Carboplatin in 2021
3.2 Global Carboplatin Revenue by Manufacturers
3.2.1 Global Carboplatin Revenue by Manufacturers (2017-2022)
3.2.2 Global Carboplatin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Carboplatin Revenue in 2021
3.3 Global Carboplatin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Carboplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Carboplatin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Carboplatin Sales by Type
4.1.1 Global Carboplatin Historical Sales by Type (2017-2022)
4.1.2 Global Carboplatin Forecasted Sales by Type (2023-2028)
4.1.3 Global Carboplatin Sales Market Share by Type (2017-2028)
4.2 Global Carboplatin Revenue by Type
4.2.1 Global Carboplatin Historical Revenue by Type (2017-2022)
4.2.2 Global Carboplatin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Carboplatin Revenue Market Share by Type (2017-2028)
4.3 Global Carboplatin Price by Type
4.3.1 Global Carboplatin Price by Type (2017-2022)
4.3.2 Global Carboplatin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Carboplatin Sales by Application
5.1.1 Global Carboplatin Historical Sales by Application (2017-2022)
5.1.2 Global Carboplatin Forecasted Sales by Application (2023-2028)
5.1.3 Global Carboplatin Sales Market Share by Application (2017-2028)
5.2 Global Carboplatin Revenue by Application
5.2.1 Global Carboplatin Historical Revenue by Application (2017-2022)
5.2.2 Global Carboplatin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Carboplatin Revenue Market Share by Application (2017-2028)
5.3 Global Carboplatin Price by Application
5.3.1 Global Carboplatin Price by Application (2017-2022)
5.3.2 Global Carboplatin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Carboplatin Market Size by Type
6.1.1 North America Carboplatin Sales by Type (2017-2028)
6.1.2 North America Carboplatin Revenue by Type (2017-2028)
6.2 North America Carboplatin Market Size by Application
6.2.1 North America Carboplatin Sales by Application (2017-2028)
6.2.2 North America Carboplatin Revenue by Application (2017-2028)
6.3 North America Carboplatin Market Size by Country
6.3.1 North America Carboplatin Sales by Country (2017-2028)
6.3.2 North America Carboplatin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Carboplatin Market Size by Type
7.1.1 Europe Carboplatin Sales by Type (2017-2028)
7.1.2 Europe Carboplatin Revenue by Type (2017-2028)
7.2 Europe Carboplatin Market Size by Application
7.2.1 Europe Carboplatin Sales by Application (2017-2028)
7.2.2 Europe Carboplatin Revenue by Application (2017-2028)
7.3 Europe Carboplatin Market Size by Country
7.3.1 Europe Carboplatin Sales by Country (2017-2028)
7.3.2 Europe Carboplatin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Carboplatin Market Size by Type
8.1.1 Asia Pacific Carboplatin Sales by Type (2017-2028)
8.1.2 Asia Pacific Carboplatin Revenue by Type (2017-2028)
8.2 Asia Pacific Carboplatin Market Size by Application
8.2.1 Asia Pacific Carboplatin Sales by Application (2017-2028)
8.2.2 Asia Pacific Carboplatin Revenue by Application (2017-2028)
8.3 Asia Pacific Carboplatin Market Size by Region
8.3.1 Asia Pacific Carboplatin Sales by Region (2017-2028)
8.3.2 Asia Pacific Carboplatin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Carboplatin Market Size by Type
9.1.1 Latin America Carboplatin Sales by Type (2017-2028)
9.1.2 Latin America Carboplatin Revenue by Type (2017-2028)
9.2 Latin America Carboplatin Market Size by Application
9.2.1 Latin America Carboplatin Sales by Application (2017-2028)
9.2.2 Latin America Carboplatin Revenue by Application (2017-2028)
9.3 Latin America Carboplatin Market Size by Country
9.3.1 Latin America Carboplatin Sales by Country (2017-2028)
9.3.2 Latin America Carboplatin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Carboplatin Market Size by Type
10.1.1 Middle East and Africa Carboplatin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Carboplatin Revenue by Type (2017-2028)
10.2 Middle East and Africa Carboplatin Market Size by Application
10.2.1 Middle East and Africa Carboplatin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Carboplatin Revenue by Application (2017-2028)
10.3 Middle East and Africa Carboplatin Market Size by Country
10.3.1 Middle East and Africa Carboplatin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Carboplatin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Overview
11.2.3 Fresenius Kabi Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Fresenius Kabi Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Fresenius Kabi Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Qilu
11.4.1 Qilu Corporation Information
11.4.2 Qilu Overview
11.4.3 Qilu Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Qilu Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Qilu Recent Developments
11.5 Taj Pharmaceuticals
11.5.1 Taj Pharmaceuticals Corporation Information
11.5.2 Taj Pharmaceuticals Overview
11.5.3 Taj Pharmaceuticals Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Taj Pharmaceuticals Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Taj Pharmaceuticals Recent Developments
11.6 Tecoland Corporation
11.6.1 Tecoland Corporation Corporation Information
11.6.2 Tecoland Corporation Overview
11.6.3 Tecoland Corporation Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Tecoland Corporation Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tecoland Corporation Recent Developments
11.7 Johnson Matthey
11.7.1 Johnson Matthey Corporation Information
11.7.2 Johnson Matthey Overview
11.7.3 Johnson Matthey Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson Matthey Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson Matthey Recent Developments
11.8 Heraeus Deutschland
11.8.1 Heraeus Deutschland Corporation Information
11.8.2 Heraeus Deutschland Overview
11.8.3 Heraeus Deutschland Carboplatin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Heraeus Deutschland Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Heraeus Deutschland Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Carboplatin Industry Chain Analysis
12.2 Carboplatin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Carboplatin Production Mode & Process
12.4 Carboplatin Sales and Marketing
12.4.1 Carboplatin Sales Channels
12.4.2 Carboplatin Distributors
12.5 Carboplatin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Carboplatin Industry Trends
13.2 Carboplatin Market Drivers
13.3 Carboplatin Market Challenges
13.4 Carboplatin Market Restraints
14 Key Findings in The Global Carboplatin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Carboplatin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Carboplatin Crystal
Table 3. Major Manufacturers of Carboplatin Powder
Table 4. Global Carboplatin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Carboplatin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Carboplatin Sales by Region (2017-2022) & (K MT)
Table 7. Global Carboplatin Sales Market Share by Region (2017-2022)
Table 8. Global Carboplatin Sales by Region (2023-2028) & (K MT)
Table 9. Global Carboplatin Sales Market Share by Region (2023-2028)
Table 10. Global Carboplatin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Carboplatin Revenue Market Share by Region (2017-2022)
Table 12. Global Carboplatin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Carboplatin Revenue Market Share by Region (2023-2028)
Table 14. Global Carboplatin Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Carboplatin Sales Share by Manufacturers (2017-2022)
Table 16. Global Carboplatin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Carboplatin Revenue Share by Manufacturers (2017-2022)
Table 18. Carboplatin Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Carboplatin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Carboplatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carboplatin as of 2021)
Table 21. Carboplatin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Carboplatin Product Offered
Table 23. Date of Manufacturers Enter into Carboplatin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Carboplatin Sales by Type (2017-2022) & (K MT)
Table 26. Global Carboplatin Sales by Type (2023-2028) & (K MT)
Table 27. Global Carboplatin Sales Share by Type (2017-2022)
Table 28. Global Carboplatin Sales Share by Type (2023-2028)
Table 29. Global Carboplatin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Carboplatin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Carboplatin Revenue Share by Type (2017-2022)
Table 32. Global Carboplatin Revenue Share by Type (2023-2028)
Table 33. Carboplatin Price by Type (2017-2022) & (USD/MT)
Table 34. Global Carboplatin Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Carboplatin Sales by Application (2017-2022) & (K MT)
Table 36. Global Carboplatin Sales by Application (2023-2028) & (K MT)
Table 37. Global Carboplatin Sales Share by Application (2017-2022)
Table 38. Global Carboplatin Sales Share by Application (2023-2028)
Table 39. Global Carboplatin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Carboplatin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Carboplatin Revenue Share by Application (2017-2022)
Table 42. Global Carboplatin Revenue Share by Application (2023-2028)
Table 43. Carboplatin Price by Application (2017-2022) & (USD/MT)
Table 44. Global Carboplatin Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Carboplatin Sales by Type (2017-2022) & (K MT)
Table 46. North America Carboplatin Sales by Type (2023-2028) & (K MT)
Table 47. North America Carboplatin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Carboplatin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Carboplatin Sales by Application (2017-2022) & (K MT)
Table 50. North America Carboplatin Sales by Application (2023-2028) & (K MT)
Table 51. North America Carboplatin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Carboplatin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Carboplatin Sales by Country (2017-2022) & (K MT)
Table 54. North America Carboplatin Sales by Country (2023-2028) & (K MT)
Table 55. North America Carboplatin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Carboplatin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Carboplatin Sales by Type (2017-2022) & (K MT)
Table 58. Europe Carboplatin Sales by Type (2023-2028) & (K MT)
Table 59. Europe Carboplatin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Carboplatin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Carboplatin Sales by Application (2017-2022) & (K MT)
Table 62. Europe Carboplatin Sales by Application (2023-2028) & (K MT)
Table 63. Europe Carboplatin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Carboplatin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Carboplatin Sales by Country (2017-2022) & (K MT)
Table 66. Europe Carboplatin Sales by Country (2023-2028) & (K MT)
Table 67. Europe Carboplatin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Carboplatin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Carboplatin Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Carboplatin Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Carboplatin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Carboplatin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Carboplatin Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Carboplatin Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Carboplatin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Carboplatin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Carboplatin Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Carboplatin Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Carboplatin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Carboplatin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Carboplatin Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Carboplatin Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Carboplatin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Carboplatin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Carboplatin Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Carboplatin Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Carboplatin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Carboplatin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Carboplatin Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Carboplatin Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Carboplatin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Carboplatin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Carboplatin Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Carboplatin Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Carboplatin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Carboplatin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Carboplatin Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Carboplatin Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Carboplatin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Carboplatin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Carboplatin Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Carboplatin Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Carboplatin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Carboplatin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Teva Corporation Information
Table 106. Teva Description and Major Businesses
Table 107. Teva Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Teva Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Teva Recent Developments
Table 110. Fresenius Kabi Corporation Information
Table 111. Fresenius Kabi Description and Major Businesses
Table 112. Fresenius Kabi Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Fresenius Kabi Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Fresenius Kabi Recent Developments
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Major Businesses
Table 117. Mylan Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Mylan Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Mylan Recent Developments
Table 120. Qilu Corporation Information
Table 121. Qilu Description and Major Businesses
Table 122. Qilu Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Qilu Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Qilu Recent Developments
Table 125. Taj Pharmaceuticals Corporation Information
Table 126. Taj Pharmaceuticals Description and Major Businesses
Table 127. Taj Pharmaceuticals Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Taj Pharmaceuticals Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Taj Pharmaceuticals Recent Developments
Table 130. Tecoland Corporation Corporation Information
Table 131. Tecoland Corporation Description and Major Businesses
Table 132. Tecoland Corporation Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Tecoland Corporation Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Tecoland Corporation Recent Developments
Table 135. Johnson Matthey Corporation Information
Table 136. Johnson Matthey Description and Major Businesses
Table 137. Johnson Matthey Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Johnson Matthey Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Johnson Matthey Recent Developments
Table 140. Heraeus Deutschland Corporation Information
Table 141. Heraeus Deutschland Description and Major Businesses
Table 142. Heraeus Deutschland Carboplatin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Heraeus Deutschland Carboplatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Heraeus Deutschland Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Carboplatin Distributors List
Table 148. Carboplatin Customers List
Table 149. Carboplatin Market Trends
Table 150. Carboplatin Market Drivers
Table 151. Carboplatin Market Challenges
Table 152. Carboplatin Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Carboplatin Product Picture
Figure 3. Global Carboplatin Market Share by Type in 2021 & 2028
Figure 3. Carboplatin Crystal Product Picture
Figure 4. Carboplatin Powder Product Picture
Figure 5. Global Carboplatin Market Share by Application in 2021 & 2028
Figure 6. Carboplatin Injection
Figure 7. Others
Figure 8. Carboplatin Report Years Considered
Figure 9. Global Carboplatin Sales 2017-2028 (K MT)
Figure 10. Global Carboplatin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Carboplatin Revenue 2017-2028 (US$ Million)
Figure 12. Global Carboplatin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Carboplatin Sales Market Share by Region (2017-2022)
Figure 14. Global Carboplatin Sales Market Share by Region (2023-2028)
Figure 15. North America Carboplatin Sales YoY (2017-2028) & (K MT)
Figure 16. North America Carboplatin Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Carboplatin Sales YoY (2017-2028) & (K MT)
Figure 18. Europe Carboplatin Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Carboplatin Sales YoY (2017-2028) & (K MT)
Figure 20. Asia-Pacific Carboplatin Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Carboplatin Sales YoY (2017-2028) & (K MT)
Figure 22. Latin America Carboplatin Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Carboplatin Sales YoY (2017-2028) & (K MT)
Figure 24. Middle East & Africa Carboplatin Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Carboplatin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Carboplatin in the World: Market Share by Carboplatin Revenue in 2021
Figure 27. Global Carboplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Carboplatin Sales Market Share by Type (2017-2028)
Figure 29. Global Carboplatin Revenue Market Share by Type (2017-2028)
Figure 30. Global Carboplatin Sales Market Share by Application (2017-2028)
Figure 31. Global Carboplatin Revenue Market Share by Application (2017-2028)
Figure 32. North America Carboplatin Sales Market Share by Type (2017-2028)
Figure 33. North America Carboplatin Revenue Market Share by Type (2017-2028)
Figure 34. North America Carboplatin Sales Market Share by Application (2017-2028)
Figure 35. North America Carboplatin Revenue Market Share by Application (2017-2028)
Figure 36. North America Carboplatin Sales Share by Country (2017-2028)
Figure 37. North America Carboplatin Revenue Share by Country (2017-2028)
Figure 38. U.S. Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Carboplatin Sales Market Share by Type (2017-2028)
Figure 41. Europe Carboplatin Revenue Market Share by Type (2017-2028)
Figure 42. Europe Carboplatin Sales Market Share by Application (2017-2028)
Figure 43. Europe Carboplatin Revenue Market Share by Application (2017-2028)
Figure 44. Europe Carboplatin Sales Share by Country (2017-2028)
Figure 45. Europe Carboplatin Revenue Share by Country (2017-2028)
Figure 46. Germany Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 47. France Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Carboplatin Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Carboplatin Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Carboplatin Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Carboplatin Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Carboplatin Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Carboplatin Revenue Share by Region (2017-2028)
Figure 57. China Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 60. India Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Carboplatin Sales Market Share by Type (2017-2028)
Figure 68. Latin America Carboplatin Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Carboplatin Sales Market Share by Application (2017-2028)
Figure 70. Latin America Carboplatin Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Carboplatin Sales Share by Country (2017-2028)
Figure 72. Latin America Carboplatin Revenue Share by Country (2017-2028)
Figure 73. Mexico Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Carboplatin Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Carboplatin Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Carboplatin Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Carboplatin Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Carboplatin Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Carboplatin Revenue Share by Country (2017-2028)
Figure 82. Turkey Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Carboplatin Revenue (2017-2028) & (US$ Million)
Figure 85. Carboplatin Value Chain
Figure 86. Carboplatin Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed